biotech
mTOR Inhibitor Designated as Orphan Drug
Filed in archive Drugs, Vaccines and Therapeutics by ruth on August 23, 2005
BlogPicture

ARIAD Pharmaceuticals, Inc. announced last week that AP23573, its novel mTOR inhibitor, has been designated an orphan drug by the United States Food and Drug Administration (FDA) for the treatment of both soft-tissue and bone sarcomas.

Designated as an "orphan drug", it will enjoy the following perks:

  • funding for certain clinical studies

  • study-design assistance

  • waiver of Prescription Drug User Fee Act (PDUFA) fees

  • tax credits

  • up to seven years of market exclusivity for the product upon regulatory approval


  • "In the absence of any effective treatments for advanced soft-tissue sarcomas or refractory bone sarcomas that have spread, the orphan drug designations for AP23573 provided by the FDA should help us address this unmet medical need more effectively," said Harvey J. Berger, M.D., chairman and chief executive officer of ARIAD. "We are working with key regulatory agencies to advance AP23573 toward its initial registration trial and subsequent regulatory submissions for marketing authorization in these devastating cancers."


    AP23573, starves cancer cells and shrinks tumors by inhibiting the critical cell-signaling protein, mTOR, which regulates the response of tumor cells to nutrients and growth factors, and controls tumor blood supply and angiogenesis. AP23573 is targeted at the treatment of bone and soft-tissue sarcomas and is in Phase 2 trials. Read more here.



Permalink: mTOR Inhibitor Designated as Orphan Drug
Tags: sarcoma  drug  biotech  orphan  mtor  orphan+drug  designated+orphan  mtor+inhibitor 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/8582
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for mTOR Inhibitor Designated as Orphan Drug:

  • Currently 7.86/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 7.86 out of 7 vote(s) cast.
 
Subscribe
Share It
Popular posts from our other blogs:
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!